Silverberg Bernstein Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Buy |
85,317
+13,157
| +18% | +$221K | 0.98% | 31 |
|
|
2025
Q1 | $1.11M | Buy |
72,160
+3,720
| +5% | +$57.2K | 1.03% | 28 |
|
|
2024
Q4 | $1.51M | Sell |
68,440
-600
| -0.9% | -$13.2K | 1.33% | 19 |
|
|
2024
Q3 | $1.24M | Buy |
69,040
+1,800
| +3% | +$32.4K | 1.14% | 22 |
|
|
2024
Q2 | $1.09M | Hold |
67,240
| – | – | 1.06% | 26 |
|
|
2024
Q1 | $949K | Hold |
67,240
| – | – | 0.93% | 29 |
|
|
2023
Q4 | $702K | Buy |
+67,240
| New | +$702K | 0.67% | 32 |
|